Review Article
Pediatric Migraine
Table 5
Treatment of acute attacks of migraine.
| Class | Drug | Comments |
| Analgesics | Ibuprofen, PO 7.5–10 mg/kg | First line drug; safe and effective in children | Acetaminofen, PO 15 mg/kg | Comparable efficacy and safety profile with ibuprofen | Nimuselide, PO 2.5 mg/kg | |
| Triptans | Sumatriptan Nasal spray, 5 mg, 20 mg | Easy administration, faster initial relief, and more side effects as compared to placebo | Subcutaneous, 0.06 mg/kg | Administration difficulty, chest and neck discomfort, and reported side effects | Oral, 50 to 100 mg | Not effective | Rizatriptan, PO, 5 mg | Studied in adolescent; adverse effects reported were fatigue, dizziness, somnolence, dry mouth, and nausea | Zolmitriptan, PO 2.5–5 mg | Evaluated in 12–17 years |
| Other medication | Ketorolac IV 0.5 mg/kg; maximum 30 mg | IV prochlorperazine is superior to IV ketorolac in the acute treatment of migraine headaches in emergency department | prochlorperazine IV (0.15 mg/kg; maximum 10 mg) | |
|
|